The majority of kinase inhibitors that have been developed so far—known as type I inhibitors—
target the ATP binding site of the kinase in its active conformation, in which the activation …

Many of the kinase inhibitors that have been developed such as the type I inhibitors target
the ATP binding site of the kinase. Crystal structures of inhibitors like imatinib (STI571) …

Rational design of inhibitors that bind to inactive kinase conformations | CiNii Research CiNii
国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データを …

The majority of kinase inhibitors that have been developed so far--known as type I inhibitors--
target the ATP binding site of the kinase in its active conformation, in which the activation …

The majority of kinase inhibitors that have been developed so far--known as type I inhibitors--
target the ATP binding site of the kinase in its active conformation, in which the activation …

The majority of kinase inhibitors that have been developed so far—known as type I inhibitors—
target the ATP binding site of the kinase in its active conformation, in which the activation …

The majority of kinase inhibitors that have been developed so far—known as type I inhibitors—
target the ATP binding site of the kinase in its active conformation, in which the activation …